tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Dechert, 5 are a BUY (100%).
Analyst Steve Dechert, currently employed at KEYBANK, carries an average stock price target met ratio of 25% that have a potential upside of 19.59% achieved within 7 days.
Steve Dechert’s has documented 9 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 25-Feb-2026.
Analyst best performing recommendations are on LFMD (LIFEMD).
The best stock recommendation documented was for LFMD (LIFEMD) at 4/16/2025. The price target of $7 was fulfilled within 13 days with a profit of $1.97 (39.17%) receiving and performance score of 30.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jan-2025
$26
$-0.37 (-1.40%)
$24
14 days ago
(22-Jul-2026)
13/18 (72.22%)
$0.66 (2.60%)
286
Buy Since 15-Oct-2018
$32
$5.63 (21.35%)
$15
1 months 18 days ago
(18-Jun-2026)
4/6 (66.67%)
$7.78 (32.12%)
56
Buy Since 19-Feb-2026
$30
$3.63 (13.77%)
$28
2 months 29 days ago
(07-May-2026)
4/8 (50%)
$5.99 (24.95%)
710
Buy Since 21-Nov-2025
$29
$2.63 (9.97%)
$27
5 months 11 days ago
(25-Feb-2026)
0/2 (0%)
$2.16 (8.05%)
Buy Since 05-Nov-2025
$30
$3.63 (13.77%)
$26
5 months 12 days ago
(24-Feb-2026)
5/7 (71.43%)
$3.62 (13.72%)
82
Which stock is Steve Dechert is most bullish on?
What Year was the first public recommendation made by Steve Dechert?
